Literature DB >> 12534769

Remedies needed to address the pathology in reporting adverse reactions and Food and Drug Administration use of reports.

Sidney M Wolfe.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 12534769      PMCID： PMC1494800     

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  5 in total

1.  Safety of FDA-approved drugs.

Authors:  P Lurie; L D Sasich
Journal:  JAMA       Date:  1999 Dec 22-29       Impact factor: 56.272

2.  Lotronex and the FDA: a fatal erosion of integrity.

Authors:  R Horton
Journal:  Lancet       Date:  2001-05-19       Impact factor: 79.321

3.  Adverse drug event monitoring at the Food and Drug Administration.

Authors:  Syed Rizwanuddin Ahmad
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

4.  Measuring errors and adverse events in health care.

Authors:  Eric J Thomas; Laura A Petersen
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 5.128

5.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272
  5 in total
  1 in total

1.  Pharma's bad karma. Resistance is not futile.

Authors:  Olveen Carrasquillo; Robert L Goodman
Journal:  J Gen Intern Med       Date:  2003-04       Impact factor: 5.128
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.